Revenue | ₹170.73Cr |
Net Profits | ₹4.18Cr |
Net Profit Margins | 2.45% |
Sudarshan Pharma Industries Ltd’s revenue jumped 32.44% since last year same period to ₹170.73Cr in the Q2 2025-2026. On a quarterly growth basis, Sudarshan Pharma Industries Ltd has generated 16.56% jump in its revenue since last 3-months.
Sudarshan Pharma Industries Ltd’s net profit fell -28.91% since last year same period to ₹4.18Cr in the Q2 2025-2026. On a quarterly growth basis, Sudarshan Pharma Industries Ltd has generated 3.47% jump in its net profits since last 3-months.
Sudarshan Pharma Industries Ltd’s net profit margin fell -46.32% since last year same period to 2.45% in the Q2 2025-2026. On a quarterly growth basis, Sudarshan Pharma Industries Ltd has generated -11.24% fall in its net profit margins since last 3-months.
The revenue for Sudarshan Pharma Industries Ltd in the Q2 results 2025 was ₹170.73Cr.
The net profit for Sudarshan Pharma Industries Ltd in the Q2 results 2025 was ₹4.18Cr.
The net profit margin for Sudarshan Pharma Industries Ltd in the Q2 results 2025 was 2.45%.
The revenue for Sudarshan Pharma Industries Ltd in the Q2 results 2024 was ₹128.91Cr.
The net profit for Sudarshan Pharma Industries Ltd in the Q2 results 2024 was ₹5.88Cr.
The net profit margin for Sudarshan Pharma Industries Ltd in the Q2 results 2024 was 4.56%.